WHERE THE ROAD AHEAD HAS LED TO...
will only evolve further as bioanalysis continues to advance.
It is positive to see that the optimism expressed 2 years ago has since materialized to an extent – this wasn’t a case of a lackadaisical interest expressed by the community, but rather a deeply sincere and carefully measured desire to gain a better understanding of how they can do better science, and gain high-quality data in a more ethical and economical way.
Two years later we see this sincerity materializing – according to our recent survey there has been a 20% increase in the application of microsampling compared with the results generated by our microsampling Spotlight 2 years ago. Our recent survey further showed that although microsampling is still more common in nonclinical contexts, there has been a significant increase in the application of microsampling in clinical research, this is a promising finding of microsampling’s high potential.
In her commentary on the 2014 survey results, Kathryn Chapman (Executive Manager at Milner Therapeutics Institute, Cambridge University; Cambridge, UK) highlighted the emphasis that companies are placing on the three Rs, with two of the five major reasons for implementing microsampling being reduction in the number of animals and refinement of procedures, reducing animal stress. It is positive to see that these same reasons continue to drive the industry to apply microsampling and in the process pave the way to achieving better science.
Perhaps it is the strong scientific spirit evident through the non-competitive collaboration
across companies in this field, evidenced in recent microsampling workshops, which reflects the optimism that best captures the future of microsampling.
Below are some of the top content from our 2014 Spotlight Microsampling: the road ahead hosted on Bioanalysis Zone. Revisit this Spotlight to see how the field has developed and what issues still remain.
HIGHLIGHTS FROM SPOTLIGHT ON MICROSAMPLING: THE ROAD AHEAD • Microsampling Panel Discussion • Microsampling: the road ahead Survey Infographic • Interview with Roger Hayes (MPI Research) on microsampling in drug discovery and development • Microsampling and the bioanalytical challenges in their routine analysis • Microsampling: is the future bright? • Interview with Sufyan Maqbool (MedImmune) on capillary microsampling
13
www.bioanalysis-zone.com
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48
